🇺🇸 Intraperitoneal Lignocaine in United States

Intraperitoneal Lignocaine (Intraperitoneal Lignocaine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intraperitoneal Lignocaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intraperitoneal Lignocaine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intraperitoneal Lignocaine in United States?

Jawaharlal Institute of Postgraduate Medical Education & Research is the originator. The local marketing authorisation holder may differ — check the official source linked above.